BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30327774)

  • 1. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.
    Xie L; Li LY; Zheng D; Xie YM; Xu XE; Tao LH; Liao LD; Xie YH; Cheng YW; Xu LY; Li EM
    Biomed Res Int; 2018; 2018():2049313. PubMed ID: 30327774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation.
    Li LY; Jiang H; Xie YM; Liao LD; Cao HH; Xu XE; Chen B; Zeng FM; Zhang YL; Du ZP; Chen H; Huang W; Jia W; Zheng W; Xie JJ; Li EM; Xu LY
    Oncotarget; 2015 Jun; 6(18):15940-52. PubMed ID: 25909284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
    Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
    Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis.
    Feng YF; Lei YY; Lu JB; Xi SY; Zhang Y; Huang QT; Wu QL; Wang F
    Cell Death Dis; 2018 Oct; 9(11):1085. PubMed ID: 30348939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics reveals the downregulation of GRB2 as a prominent node of F806-targeted cell proliferation network.
    Li LY; Zhang K; Jiang H; Xie YM; Liao LD; Chen B; Du ZP; Zhang PX; Chen H; Huang W; Jia W; Cao HH; Zheng W; Li EM; Xu LY
    J Proteomics; 2015 Mar; 117():145-55. PubMed ID: 25659534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.
    Ma S; Lu CC; Yang LY; Wang JJ; Wang BS; Cai HQ; Hao JJ; Xu X; Cai Y; Zhang Y; Wang MR
    J Exp Clin Cancer Res; 2018 Aug; 37(1):183. PubMed ID: 30081903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo.
    Liang F; Wang YG; Wang C
    Cell Physiol Biochem; 2018; 51(3):1276-1286. PubMed ID: 30481793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis.
    Li M; Wang L; Zhan Y; Zeng T; Zhang X; Guan XY; Li Y
    Am J Pathol; 2019 Jul; 189(7):1462-1472. PubMed ID: 31054987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma.
    Niu G; Zhuang H; Li B; Cao G
    J BUON; 2018; 23(1):157-162. PubMed ID: 29552776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes.
    Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM
    Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RND1 is up-regulated in esophageal squamous cell carcinoma and promotes the growth and migration of cancer cells.
    Xiang G; Yi Y; Weiwei H; Weiming W
    Tumour Biol; 2016 Jan; 37(1):773-9. PubMed ID: 26250459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis.
    Luo ML; Zhou Z; Sun L; Yu L; Sun L; Liu J; Yang Z; Ran Y; Yao Y; Hu H
    Cancer Lett; 2018 May; 422():118-128. PubMed ID: 29476791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.
    Xie YH; Li LY; He JZ; Xu XE; Liao LD; Zhang Q; Xie JJ; Xu LY; Li EM
    Int J Biochem Cell Biol; 2019 Jul; 112():79-87. PubMed ID: 31082616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase transition process.
    Ke Y; Guo W; Huang S; Li Y; Guo Y; Liu X; Jin Y; Ma H
    Life Sci; 2020 Jun; 250():117578. PubMed ID: 32209426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
    Chen L; Bi S; Wei Q; Zhao Z; Wang C; Xie S
    J Cell Mol Med; 2020 May; 24(9):5387-5401. PubMed ID: 32237037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma.
    Li T; Xu L; Teng J; Ma Y; Liu W; Wang Y; Chi X; Shao S; Dong Y; Zhan Q; Liu X
    Dig Dis Sci; 2020 Apr; 65(4):1032-1041. PubMed ID: 31562612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.
    Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rho GTPase RhoE exerts tumor-suppressing effects in human esophageal squamous cell carcinoma via negatively regulating epidermal growth factor receptor.
    Wang H; Wang Y; Liang B; He F; Li Y; Che J; Li X; Zhao H; Shi G
    J Cancer Res Ther; 2016 Oct; 12(Supplement):60-63. PubMed ID: 27721256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.